Probactrix OTC Approval Sought Over Rx Path For Diarrhea Drug
This article was originally published in The Tan Sheet
Executive Summary
BioBalance Corp. plans to submit an application to FDA for OTC approval of its Probactrix antibiotic-associated diarrhea drug in the first quarter of 2004, pending positive results from an ongoing safety study
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning